«Australia is absolutely punching above its weight in life science,» says Anna Lavelle, CEO of AusBiotech, Ltd. «It has 0.3 percent of the global population, 2.8 percent of peer - reviewed papers, and
significant global patents.
«Dorne will add
global expertise to our nationally recognized trademark department, while Kristin, Linda and Rachel will be
significant additions to our medical device and life science practice, particularly in the areas of
patent litigation, mechanical and electrical
patent prosecution.»